Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by jojomarchon Jan 28, 2020 4:31pm
113 Views
Post# 30610721

RE:Frost clarification

RE:Frost clarification
Macer wrote: Can someone take the time to give me a high level breifing on the Frost situation?
I have not taken the time to read into it in detail. But from what I understand from peoples posts are that TLT is intentionally keeping the SP at these levels to prevent Frost from firming up on the warrants that expire in March. Correct?

Why on earth woudn;t he just buy more shares in the market at these prices? I understandd that may drive the price up but there is a lot of room between here and $0.54.

Macer


I cannot help because i am clueless of the whole Frost situation . There is too many moving pieces for my simple approach to things . The business strategy is hard to understand , i can only recap .

In March of 2015 TLT issued almost 20 million shares at 44 cents with 20 million attached warrants to be exersized at 54 cents 5 years later . If my memory serves me right we were lead to believe that down the roa
d an important investor would prove useful .

Now late this summer , more than 4 years later , with not one but two CR patients at more than 360 days and proven in animal studies for a few different indications TLT issues 60 million shares at 30 cents with 60 million 5 year warrants at 35 cents knowing that just a little over 6 months , 20 million warrants could come in for $10 million of funds ....business acumen ?

Am i being a simpleton ? I am dissapointed , management can prove to us minority shareholders they can show us the goods . 

Still hoping for better days ahead with this investment

GLTA



Bullboard Posts